Trends in utilization of glucagon-like peptide‑1 receptor agonists, sodium-glucose cotransporter‑2 inhibitors, and metabolic bariatric surgery in U.S. adults with diabetes and obesity.

This is a source-metadata record last found in a complete check on Sep 28, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.

Study metadata

Study type: Original study
Study category (metadata hint): Other or unclear
Source date: Published: 2026-08-20
Authors: Wartko PD, Zhang R, Johnson E, Begle C, Bobb JF, Chen C, Singh A, Ross L
Journal or registry: Not reported
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: NIDDK NIH HHS; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; NIA NIH HHS
Identifiers: DOI: 10.1016/j.diabres.2026.113504 · PMID: 42624330
First found: Sep 28, 2026
Last found: Sep 28, 2026

Original sources

View at Europe PMC ↗